Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Versant Ventures VII GP-GP, LLC — LENZ Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Versant Ventures VII GP-GP, LLC

Versant Ventures VII GP-GP, LLC

10% owner at RayzeBio, Inc. · on record since Sep 14, 2023
10% owner at LENZ Therapeutics, Inc. · on record since Mar 25, 2024

Insider trading activity of Versant Ventures VII GP-GP, LLC

Transactions on record: 1; since Jul 14, 2025

Open-market buys: 0

Open-market sells: 1; $6.5M

Companies traded: 1; last filing Jul 14, 2025

Figures computed from official regulatory filings — methodology.

Companies where Versant Ventures VII GP-GP, LLC has traded

LENZ Therapeutics, Inc.1 tx · $6.5M · Jul 14, 2025

Track record of Versant Ventures VII GP-GP, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Versant Ventures VII GP-GP, LLC

Co-insiders of Versant Ventures VII GP-GP, LLC

Versant Venture Capital VII, L.P.LENZ Therapeutics, Inc. +1
Versant Ventures VII GP, L.P.LENZ Therapeutics, Inc. +1
Adelman Robert JRayzeBio, Inc.
Alpha Wave Ventures GP, LtdLENZ Therapeutics, Inc.
Chevallard Daniel R.LENZ Therapeutics, Inc.
Chimera Investment LLCLENZ Therapeutics, Inc.
Drapkin Kimberlee CLENZ Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Falcon Edge Capital, LPLENZ Therapeutics, Inc.

George Jeffrey P.LENZ Therapeutics, Inc.

GOODMAN COREY SRayzeBio, Inc.

Green JeremyRayzeBio, Inc.

Guerard FredericLENZ Therapeutics, Inc.

HALVORSEN OLE ANDREASRayzeBio, Inc.

Heyman Richard A.RayzeBio, Inc.

Katabi MahaRayzeBio, Inc.

Kolchinsky PeterLENZ Therapeutics, Inc.

Kush ArvindRayzeBio, Inc.

Larson YiRayzeBio, Inc.

Lunate Holding RSC LtdLENZ Therapeutics, Inc.

MCCOLLUM JAMES WLENZ Therapeutics, Inc.

Moran SusanRayzeBio, Inc.

Odrich MarcLENZ Therapeutics, Inc.

Oliger Christy J.RayzeBio, Inc.

Olsson ShawnLENZ Therapeutics, Inc.

Ott David C.RayzeBio, Inc.

RA Capital Biotech Fund LPLENZ Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCLENZ Therapeutics, Inc.

RA Capital Nexus Fund II, L.P.LENZ Therapeutics, Inc.

Redmile Biopharma Investments II, L.P.RayzeBio, Inc.

Redmile Group, LLCRayzeBio, Inc.

Royston AaronRayzeBio, Inc.

Scheiner ZacharyLENZ Therapeutics, Inc.

Schimmelpennink Evert B.LENZ Therapeutics, Inc.

Shabet Rose SharonRayzeBio, Inc.

Shah Rajeev M.LENZ Therapeutics, Inc.

SONG KENNETHRayzeBio, Inc.

TAGLIAFERRI MARYRayzeBio, Inc.

Thunen Shelley BLENZ Therapeutics, Inc.

Van Hauwermeiren TimothyRayzeBio, Inc.

venBio Global Strategic Fund III, L.P.RayzeBio, Inc.

VENBIO GLOBAL STRATEGIC GP III, L.P.RayzeBio, Inc.

VENBIO GLOBAL STRATEGIC GP III, LTDRayzeBio, Inc.

Versant Vantage I GP-GP, LLCRayzeBio, Inc.

Versant Vantage I GP, L.P.RayzeBio, Inc.

Versant Vantage II GP-GP, LLCLENZ Therapeutics, Inc.

Versant Vantage II GP, L.P.LENZ Therapeutics, Inc.

Versant Vantage II, L.P.LENZ Therapeutics, Inc.

Versant Vantage I, L.P.RayzeBio, Inc.

Versant Venture Capital VI, L.P.LENZ Therapeutics, Inc.

Versant Ventures VI GP-GP, LLCLENZ Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
LENZ Therapeutics, Inc.	Jul 14, 2025	Sell	-191,376	34.00 USD	$6.5M	SEC